<?xml version="1.0" encoding="UTF-8"?>
<p>One of the most alarming outcomes associated with ZIKV infection during pregnancy is microcephaly (
 <xref rid="B42" ref-type="bibr">Petersen et al., 2016</xref>). While research is still ongoing to understand the relationship, Asian lineage ZIKVs have been most associated with microcephaly (
 <xref rid="B2" ref-type="bibr">Anfasa et al., 2017</xref>; 
 <xref rid="B4" ref-type="bibr">Bhatnagar et al., 2017</xref>; 
 <xref rid="B73" ref-type="bibr">Yuan et al., 2017</xref>; 
 <xref rid="B28" ref-type="bibr">Majumder et al., 2018</xref>; 
 <xref rid="B55" ref-type="bibr">Sheridan et al., 2018</xref>; 
 <xref rid="B19" ref-type="bibr">Jaeger et al., 2019</xref>; 
 <xref rid="B64" ref-type="bibr">Udenze et al., 2019</xref>). Microcephaly is a condition in which fetuses are born with small heads due to abnormal brain development. ZIKV RNA has been found in amniotic fluid as well as the brain of fetuses and infants with microcephaly (
 <xref rid="B38" ref-type="bibr">Oliveira Melo et al., 2016</xref>; 
 <xref rid="B33" ref-type="bibr">Mlakar et al., 2016</xref>). In addition to placental cells such as Hofbauer macrophages and trophoblasts, fetal brain cells are targets of ZIKV infection (
 <xref rid="B20" ref-type="bibr">Kendra et al., 2016</xref>). 
 <italic>In vitro</italic> studies have shown that neural progenitor cells, astrocytes, microglia, and oligodendrocyte precursor cells are vulnerable to ZIKV infection (
 <xref rid="B61" ref-type="bibr">Tang et al., 2016</xref>; 
 <xref rid="B47" ref-type="bibr">Retallack et al., 2016</xref>). An ability to limit ZIKV replication in mothers and/or reduce ZIKV infection of fetal brain cells may prevent microcephaly.
</p>
